hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06350669 id: 9576-22-SMC briefTitle: App-supported Vestibular Rehabilitation (RCT) overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2025-12 date: 2026-03 date: 2024-04-05 date: 2024-04-22 name: University of Haifa class: OTHER name: Sheba Medical Center name: Ben-Gurion University of the Negev briefSummary: A randomized controlled trial to assess the efficacy of an app-assisted vestibular rehabilitation in increasing adherence to VR and treatment outcomes conditions: Vestibular Disorder conditions: Vestibular Diseases conditions: Vestibular Abnormality studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The patients will be randomly assigned to either the intervention group (app-assisted vestibular rehabilitation) or the control group ("standard" vestibular rehabilitation/no app) primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 24 type: ESTIMATED name: Vestibular rehabilitation phone application measure: Adherence measures measure: Timed up and go (TUG) measure: Demographics and medical history intake measure: Vestibular functions- physical examination measure: Oculomotor functions- physical examination measure: Visual Analogue Scale (VAS) measure: Dizziness Handicap Inventory (DHI) measure: Activities-specific Balance Confidence Scale (ABC) measure: Dynamic Gait Index (DGI) measure: 10-Meters Walk Test (10MWT) measure: 2-Minute Walk Test (2MWT) measure: Dynamic Visual Acuity (DVA) measure: Video Head Impulse Test (vHIT) measure: Suppression Head Impulse Test (SHIMP) measure: Exercise difficulty levels and symptoms severity measure: Cognitive reserve index questionnaire (CRIQ) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Sheba Medical Center city: Ramat Gan country: Israel name: Yoav Gimmon, PT, Ph.D role: CONTACT email: yoavgimmon@gmail.com name: Amit Wolfovitz, M.D role: PRINCIPAL_INVESTIGATOR name: Shelly Levy-Tzedek, PhD role: PRINCIPAL_INVESTIGATOR name: Liran Kalderon, M.Sc.PT role: PRINCIPAL_INVESTIGATOR lat: 32.08227 lon: 34.81065 hasResults: False
nctId: NCT06350656 id: IRBN282022/CHUSTE briefTitle: Study of Cerebral Compliance in Neurosurgical Intensive Care Units (EC2) acronym: EC2 overallStatus: RECRUITING date: 2023-03-31 date: 2024-04 date: 2024-04 date: 2024-04-05 date: 2024-04-05 name: Centre Hospitalier Universitaire de Saint Etienne class: OTHER briefSummary: Despite the massive use of intracranial pressure in neuro-resuscitation, there is still no cerebral compliance evaluation index used in current practice to guide therapy.
In treatment guidelines for intracranial hypertension, patients are placed in a prone position at about 30 degrees. Several times a day, during nursing care, patients are flattened, which corresponds to a cerebral compliance test by adding a volume of cerebrospinal fluid to the cranial box. conditions: Cerebrospinal; Disorder studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: PROSPECTIVE count: 30 type: ESTIMATED name: Clinical data collection name: Therapeutic data collection name: IntraCranial Pression (ICP) values collection measure: Intracranial pressure (mmHg) measure: Correlation between ICP (Intra Cranial Pressure) doses and cerebral compliance sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: CENTRE HOSPITALIER Charponnay status: RECRUITING city: Chaponnay zip: 69970 country: France name: PIERRE-HENRI MURGAT, MD role: PRINCIPAL_INVESTIGATOR lat: 45.63097 lon: 4.94299 facility: CENTRE HOSPITALIER UNIVERSITAIRE Grenoble status: RECRUITING city: Grenoble zip: 38000 country: France name: JEAN FRANCOIS PAYEN, MD role: PRINCIPAL_INVESTIGATOR lat: 45.16667 lon: 5.71667 facility: HOPITAL NORD La Tronche status: RECRUITING city: La Tronche zip: 38170 country: France name: KEVIN LAGARDE, MD role: PRINCIPAL_INVESTIGATOR lat: 45.20429 lon: 5.73645 facility: APHP status: RECRUITING city: Paris zip: 75010 country: France name: SAMUEL GAUGUIN, MD role: PRINCIPAL_INVESTIGATOR lat: 48.85341 lon: 2.3488 facility: Hopital Lariboisiere - Ahph status: RECRUITING city: Paris zip: 75010 country: France name: JEROME CARTAILLIER, MD role: PRINCIPAL_INVESTIGATOR lat: 48.85341 lon: 2.3488 facility: CENTRE HOSPITALIER UNIVERSITAIRE Rennes status: RECRUITING city: Rennes zip: 35000 country: France name: YOANN LAUNEY, MD PHD role: PRINCIPAL_INVESTIGATOR lat: 48.11198 lon: -1.67429 facility: CENTRE HOSPITALIER UNIVERSITAIRE Saint-Etienne status: RECRUITING city: Saint-Étienne zip: 42055 country: France name: CLEMENT MAGAND, MD role: PRINCIPAL_INVESTIGATOR lat: 45.43389 lon: 4.39 hasResults: False
nctId: NCT06350643 id: 287064 id: P50MD017319-03S1 type: NIH link: https://reporter.nih.gov/quickSearch/P50MD017319-03S1 briefTitle: The Black Health Block Quit and Screen Project overallStatus: NOT_YET_RECRUITING date: 2024-07 date: 2024-12 date: 2024-12 date: 2024-04-05 date: 2024-04-05 name: University of Arkansas class: OTHER name: Virginia Commonwealth University name: Coalition for a Tobacco Free Arkansas name: National Institute on Minority Health and Health Disparities (NIMHD) name: National Medical Association briefSummary: The Black Health Block Quit and Screen Project seeks to engage Black health care providers in helping Black smokers quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic disease disparities.
The goal of this clinical trial is to test the feasibility and impact of the Black Health Block Culturally Tailored Training alone versus the Health Disparities and Lung Cancer Screening Training + the Black Health Block Culturally Tailored training modules on changes in knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes. conditions: Knowledge conditions: Attitudes conditions: Behavioral Intention studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: NONE count: 300 type: ESTIMATED name: Black Health Block Culturally Tailored training name: Health Disparities and Lung Cancer Screening training measure: Familiarity with treatment guidelines for tobacco and nicotine treatment measure: Weaver et al. 2012 Provider Attitudes and Perceptions about smoking cessation measure: Weaver et al. 2012 Provider Perceptions about provider barriers to providing smoking cessation interventions to patients measure: Provider Perceptions about patient barriers to smoking cessation measure: Behavioral intentions to screen and advise patients about smoking cessation measure: Familiarity with lung cancer screening guidelines measure: Knowledge about low dose computed tomography for lung cancer screening measure: Perceptions about shared decision-making for low dose computed tomography for lung cancer screening measure: Perceptions about provider barriers to referring patients to low dose computed tomography for lung cancer screening measure: Provider Perceptions about patient barriers to get screened for lung cancer measure: Behavioral intentions to advise patients to get screened for lung cancer via low dose computed tomography measure: Diversity of enrolled healthcare providers measure: Retention: Percent of providers complete the training after enrolling measure: Adherence to completing training modules: Percent of modules completed measure: Preferences regarding training measure: Satisfaction with training sex: ALL minimumAge: 21 Years maximumAge: 85 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Virginia Commonwealth Univesity city: Richmond state: Virginia zip: 23284 country: United States name: Mignonne Guy, PhD role: CONTACT phone: 804-828-1731 email: mguy@vcu.edu name: Mignonne Guy, PhD role: PRINCIPAL_INVESTIGATOR lat: 37.55376 lon: -77.46026 hasResults: False
nctId: NCT06350630 id: 20PH284 id: 2024-512653-25-00 type: CTIS briefTitle: Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study acronym: QUIgAN overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2027-12-31 date: 2030-12-31 date: 2024-04-05 date: 2024-04-05 name: Centre Hospitalier Universitaire de Saint Etienne class: OTHER name: Ministry of Health, France briefSummary: immunoglobulin A (IgA) nephropathy (Berger disease) is the most frequent primary glomerulonephritis worldwide. This disease accounts for about 5% of the causes of end stage renal disease in France, representing a major public health issue. Its pathophysiology seems to be triggered by mucosal immunity abnormalities leading to the systemic misaddressing of mucosal IgA, generation of circulating immunoglobulin A1 (IgA1) immune complexes finally deposited in renal glomeruli leading to renal tissue inflammation and scarring processes. Among this pathogeny, innate immunity is involved at several steps, including mucosal immunity.
nctId: NCT06350604 id: PRO-2023-355 briefTitle: Project WHADE: A Partner-Based Physical Activity Program for Women overallStatus: RECRUITING date: 2024-01-02 date: 2024-06 date: 2024-07 date: 2024-04-05 date: 2024-04-05 name: Rowan University class: OTHER briefSummary: This study is designed to test the feasibility and acceptability of a new method for supporting physical activity among women ages 40-65 who have risk factors for cardiovascular disease. Each participant receives a trained physical activity coach and a physical activity partner; the partner is another woman in the program. Partners communicate with each other between weekly coaching sessions to provide support for physical activity behavior change. conditions: Hypertension conditions: Type 2 Diabetes conditions: Metabolic Syndrome conditions: Smoking conditions: High Cholesterol conditions: PreDiabetes conditions: Prehypertension studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: All participants receive the same intervention primaryPurpose: PREVENTION masking: NONE count: 60 type: ESTIMATED name: Project WHADE: A Partner-Based Physical Activity Program for Women measure: Frequency of partner communication measure: Satisfaction with partner communication measure: Physical activity behavior - steps measure: Physical activity behavior - active minutes sex: FEMALE minimumAge: 40 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Rowan University status: RECRUITING city: Glassboro state: New Jersey zip: 08028 country: United States name: Sofia Gular, B.A. role: CONTACT phone: 856-256-4872 email: projectwhade@rowan.edu name: Danielle Arigo, Ph.D. role: CONTACT phone: 8562564500 phoneExt: 53775 email: arigo@rowan.edu lat: 39.70289 lon: -75.11184 hasResults: False
nctId: NCT06350591 id: 6038674 briefTitle: Evaluating Changes in Skeletal Muscle Proteins Following Resistance Exercise and Single-Leg Disuse overallStatus: RECRUITING date: 2024-04-01 date: 2024-08 date: 2024-08 date: 2024-04-05 date: 2024-04-05 name: Queen's University class: OTHER briefSummary: Skeletal muscle plays a critical role in supporting human health. Beyond its role in providing the force to move, skeletal muscle accounts for a large proportion of metabolic rate, glucose disposal, and amino acid storage. Skeletal muscle is dynamically regulated by environmental stimuli, such as loading (i.e., resistance training\]) and unloading (i.e., disuse atrophy) as well as the intake of essential amino acids (EAAs). However, the precise mechanisms that regulate skeletal muscle mass in response to various conditions (e.g., EAA supplementation, resistance training, and unloading) are not completely understood. Therefore, concerted efforts to better understand the mechanisms regulating skeletal muscle size are needed that aid in the development of therapeutic interventions to combat age, disease, and disuse related muscular atrophy. conditions: Healthy conditions: Skeletal Muscle Atrophy conditions: Skeletal Muscle Hypertrophy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: parallel, within-subject design primaryPurpose: BASIC_SCIENCE masking: NONE count: 14 type: ESTIMATED name: Immobilization name: Resistance training measure: Changes in average rates of muscle synthesis measure: Dynamic proteomic profiling measure: Protein expression (phosphorylation and content) of novel and known targets implicated in protein translation and mitochondrial-related protein expression measure: Muscle torque measure: Quadriceps skeletal muscle volume sex: FEMALE minimumAge: 18 Years maximumAge: 30 Years stdAges: ADULT facility: School of Kinesiology and Health Studies status: RECRUITING city: Kingston state: Ontario zip: K7L 3N6 country: Canada name: Chris McGlory, PhD role: CONTACT phone: 6135336000 phoneExt: 75410 email: chris.mcglory@queensu.ca name: Kristine Boileau, BSc role: CONTACT email: 22kb15@queensu.ca name: Chris McGlory, PhD role: PRINCIPAL_INVESTIGATOR lat: 44.22976 lon: -76.48101 hasResults: False
nctId: NCT06350578 id: BUHOOTH-D-23-00073 briefTitle: A Randomized Clinical Trial Comparing Hall vs. Conventional Technique in Primary Molars. overallStatus: RECRUITING date: 2023-12-06 date: 2025-03 date: 2025-06 date: 2024-04-05 date: 2024-04-05 name: Primary Health Care Corporation, Qatar class: OTHER_GOV briefSummary: This study aims to assess the comparative effectiveness of the Hall technique (HT) and the conventional technique (CT) for placing Stainless Steel Crowns (SSCs) in primary molars with approximal caries. conditions: Dental Caries studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: A binary outcome non-inferiority randomized trial. primaryPurpose: TREATMENT masking: SINGLE maskingDescription: Single-blind whoMasked: CARE_PROVIDER count: 80 type: ESTIMATED name: Hall Crown Technique name: Conventional SSC Technique measure: Restoration survival at 12 months measure: Occlusal vertical dimension (OVD) resolution measure: Tooth survival measure: Procedural time measure: Participant's cooperation measure: Participant's pain perception measure: Treatment perceptions and opinions of the parents sex: ALL minimumAge: 3 Years maximumAge: 9 Years stdAges: CHILD facility: Primary Healthcare Corporation status: RECRUITING city: Doha country: Qatar name: Research Section role: CONTACT phone: +97444069917 email: researchsection@phcc.gov.qa lat: 25.28545 lon: 51.53096 hasResults: False
nctId: NCT06350565 id: DEX20240104 briefTitle: A Clinical Pharmacological Study of Dose Halving of Dexamethasone in Pregnant Women With Preterm Labour With Preterm Birth at Greater Than or Equal to 34 Gestational Weeks (34GW+) overallStatus: NOT_YET_RECRUITING date: 2024-04-30 date: 2025-04-30 date: 2025-12-31 date: 2024-04-05 date: 2024-04-16 name: Peking University Third Hospital class: OTHER briefSummary: This study plans to conduct a DEX dose halving study and a normal dose study in 34+0-35+6 GW women with preterm preterm labour. In addition, this study plans to conduct a DEX dose halving study and a normal dose study in 34-38+6 GW preterm pregnant women with GDM or diabetic co-pregnancy to explore the feasibility of dose halving in pregnant women with diabetes mellitus. conditions: Respiratory Distress Syndrome of Newborn studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 48 type: ESTIMATED name: Dexamethasone measure: Respiratory distress syndrome measure: PK parameters (analysed in conjunction with population pharmacokinetic (PPK) modelling): area under the blood concentration curve, Cmax, Tmax, Kel, t1/2, CL, VZ measure: Pharmacodynamics measure: Measurability indicators measure: Blood biochemistry findings in newborns measure: DEX potential safety marker test sex: FEMALE minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT hasResults: False
nctId: NCT06350552 id: PA224ES-1-03 briefTitle: Prevalence of Postural Abnormalities in Dialysis Patients overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-04 date: 2024-04 date: 2024-04-05 date: 2024-04-23 name: Pardis Specialized Wellness Institute class: OTHER briefSummary: The goal of this observational study is to investigate and compare the prevalence of forward head , hyper kyphosis and balance in hemodialysis and peritoneal dialysis patients. The main questions it mains to answer are:
Participants will answer 2 questionnaires and will do some functional tests. conditions: End Stage Renal Disease conditions: Hemodialysis Complication conditions: Peritoneal Dialysis Complication studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: CROSS_SECTIONAL count: 390 type: ESTIMATED measure: Prevalence of thoracic hyper kyphosis measure: Prevalence of forward head measure: Balance level measure: Cardiopulmonary function's level measure: Fall risk level sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Khorshid Dialysis Center city: Isfahan country: Iran, Islamic Republic of lat: 32.65246 lon: 51.67462 hasResults: False
nctId: NCT06350539 id: 10-007 briefTitle: Personalized Models for Cancer Research overallStatus: RECRUITING date: 2024-02-15 date: 2034-02-15 date: 2034-02-15 date: 2024-04-05 date: 2024-04-05 name: New York Stem Cell Foundation Research Institute class: OTHER name: Stevens Institute of Technology briefSummary: The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate cancer research ranging from disease mechanisms to personalized medicine approaches that will help to realize the promise of precision medicine for oncology. conditions: Solid Tumor, Adult studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: OTHER count: 500 type: ESTIMATED name: Biological Sample Collection measure: Implement organoid culture technologies. measure: Validate genotypic and phenotypic relevance of tumor-derived organoids for biobanking. measure: Establish functional testing using organoid cultures alone or in combination with additional cell types. measure: Perform drug testing and screens to identify new targets and/or new therapeutic strategies to effectively treat cancer. measure: Develop a Laboratory Developed Test (LDT) for CLEP/FDA approval that will inform clinicians of each patient's tumor responses to FDA approved drugs. measure: Develop stem cells from individual patient samples to study tumor evolution. sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: New York Stem Cell Foundation Research Institute status: RECRUITING city: New York state: New York zip: 10019 country: United States name: Becca Wood role: CONTACT phone: 212-927-1801 email: clinicalresearch@nyscf.org name: Lisa Voltolina role: CONTACT phone: 6462133911 email: lvoltolina@nyscf.org name: Laura Andres-Martin, PhD role: PRINCIPAL_INVESTIGATOR lat: 40.71427 lon: -74.00597 hasResults: False
nctId: NCT06350526 id: PULMHEMA briefTitle: Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-03-01 date: 2025-06-01 date: 2024-04-05 date: 2024-04-05 name: New Valley University class: OTHER briefSummary: Hematologic malignancies are heterogeneous groups of neoplasia, with frequent pulmonary complications. These complications may be secondary to the patient's comorbidities, to the hemopathy itself, or its treatments. Divided into infectious and non-infectious complications, the etiologies are numerous and varied. This makes the diagnostic approach complex for the clinicians conditions: Hematologic Diseases studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: RETROSPECTIVE count: 200 type: ESTIMATED name: Complete Blood Count name: C-reactive protein name: O2 saturation name: Serum ferritin and D-dimer name: Liver and renal function tests name: Lactate dehydrogenase name: coronavirus (SARS-CoV-2) swab name: CT chest measure: Number of patients who had certain radiological patterns associated with pulmonary complications in patients diagnosed with various hematological diseases measure: Number of patients who developed complications sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06350513 id: NecmettinE briefTitle: The Effect of Animated Movies and Storybooks on Fear and Anxiety Levels in Children With Type 1 Diabetes overallStatus: NOT_YET_RECRUITING date: 2024-03-25 date: 2024-09-25 date: 2025-02-25 date: 2024-04-05 date: 2024-04-05 name: Selverhan Yurttutan class: OTHER briefSummary: This study aims to evaluate the effects of animated films and story books on the fear and anxiety levels of children with newly diagnosed type 1 diabetes. conditions: Diabetes Mellitus, Type 1 conditions: Child, Only conditions: Anxiety conditions: Fear conditions: Nurse studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Parallel Group (Experiment-Control) Randomized Controlled Experimental primaryPurpose: SUPPORTIVE_CARE masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 64 type: ESTIMATED name: Animation movie, story book measure: State Anxiety Inventory for Children (STAI-C) measure: State Anxiety Inventory for Children (STAI-C) measure: State Anxiety Inventory for Children (STAI-C) measure: Children's Fear Scale measure: Children's Fear Scale measure: Children's Fear Scale sex: ALL minimumAge: 7 Years maximumAge: 12 Years stdAges: CHILD facility: Semra Köse city: Konya state: Meram country: Turkey lat: 37.87135 lon: 32.48464 facility: Necmettin Erbakan Üniversity city: Konya country: Turkey lat: 37.87135 lon: 32.48464 hasResults: False
nctId: NCT06350500 id: I-3858823 briefTitle: A Patient Navigation Program for Addressing Disparities in Breast Cancer Care overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2026-01-01 date: 2026-01-01 date: 2024-04-05 date: 2024-04-09 name: Roswell Park Cancer Institute class: OTHER briefSummary: This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance patient skills related to management of cancer treatment. Offering a patient navigation program may increase health equity and improve social needs and quality of life over time for newly diagnosed breast cancer patients. conditions: Breast Carcinoma conditions: Breast Ductal Carcinoma in Situ studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 126 type: ESTIMATED name: Patient Navigation name: Questionnaire measure: Enrollment rate measure: Reasons for refusal measure: Retention Rate measure: Reasons for discontinuation measure: European Organization for Research and Treatment of Cancer Quality of Life Scale (EORTC QLQ-C30) measure: Social Determinates of health measure: Barriers to care measure: Use of supportive services measure: Patient Satisfaction survey sex: FEMALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False